FREE SHIPPING ON ORDERS OVER $150

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Assessing the Activity of Multidrug

$21.98

Quantity
- +
Description

[DOI] [PMC free article] [PubMed] [Google Scholar] [10].Polonikov A

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Assessing the Activity of Multidrug

10.1016/j.it.2007.03.003 [DOI] [PubMed] [Google Scholar] Miguel M

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Assessing the Activity of Multidrug

Whether they're highlighting their travelers, showcasing company culture, or finding creative ways to connect with their audience, Titan Medical Group continues to raise the bar for what great social content can look like in healthcare staffing

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Assessing the Activity of Multidrug

& Brito, I

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Assessing the Activity of Multidrug

You may also like

recommand products